检验医学 ›› 2016, Vol. 31 ›› Issue (7): 559-561.DOI: 10.3969/j.issn.1673-8640.2016.07.003

• 临床应用研究·论著 • 上一篇    下一篇

慢性阻塞性肺疾病急性加重期患者血清25-羟基维生素D检测的临床意义

顾峰   

  1. 上海市浦东新区人民医院检验科,上海 201200
  • 收稿日期:2015-09-07 出版日期:2016-07-30 发布日期:2016-08-10
  • 作者简介:null

    作者简介:顾 峰,男,1982年生,学士,主管技师,主要从事临床生化和血液体液检验工作。

Serum 25-hydroxyvitamin D determination in patients with acute exacerbation of chronic obstructive pulmonary disease

GU Feng   

  1. Department of Clinical Laboratory,Shanghai Pudong New Area People's Hospital,Shanghai 201200,China
  • Received:2015-09-07 Online:2016-07-30 Published:2016-08-10

摘要: 目的

探讨慢性阻塞性肺疾病急性加重期(AECOPD)患者血清25-羟基维生素D[25(OH)D]水平及临床意义。

方法

采用电化学发光法和免疫透射比浊法分别测定72例慢性阻塞性肺疾病(COPD)患者(AECOPD 44例、缓解期28例)和36名健康体检者(正常对照组)血清25(OH)D和C反应蛋白(CRP)水平。

结果

AECOPD组血清25(OH)D水平[(14.9±5.9)ng/mL]明显低于COPD缓解期组[(20.8± 8.0)ng/mL]及正常对照组[(23.9±8.6)ng/mL](P<0.05),而COPD缓解期组血清25(OH)D水平与正常对照组比较差异无统计学意义(P>0.05)。AECOPD组血清CRP水平[(44.5±13.3)mg/L]明显高于COPD缓解期组[(8.72±2.76)mg/L] 及正常对照组[(2.68±1.72)mg/L](P<0.05),COPD缓解期组血清CRP水平也明显高于正常对照组(P<0.05)。

结论

血清25(OH)D缺乏可能是COPD患者急性加重的危险因素之一,补充25(OH)D可能对COPD急性加重有预防作用。

关键词: 25-羟基维生素D, C反应蛋白, 慢性阻塞性肺疾病, 急性加重

Abstract:

Objective To investigate serum 25-hydroxyvitamin D [25(OH)D] determination in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods The levels of serum 25(OH)D and C-reactive protein(CRP) were determined in 72 patients with chronic obstructive pulmonary disease(COPD)(44 cases of AECOPD and 28 cases of remission of COPD) and 36 healthy subjects(healthy control group)by electrochemiluminescence and turbidimetry immunoassay. Results The level of serum 25(OH)D in AECOPD group [(14.9±5.9)ng/mL] was lower than those in COPD remission group [(20.8±8.0)ng/mL] and healthy control group [(23.9±8.6)ng/mL](P<0.05). However,there was no statistical significance for serum 25(OH)D between COPD remission group and healthy control group(P>0.05). The level of serum CRP in AECOPD group [(44.5±13.3)mg/L] was higher than those in COPD remission group [(8.72±2.76)mg/L] and healthy control group [(2.68±1.72)mg/L](P<0.05). The level of serum CRP in COPD remission group was higher than that in healthy control group(P<0.05). Conclusions The deficiency of serum 25(OH)D may be one of risk factors for AECOPD patients. The supplementation of 25(OH)D may have a preventive effect on AECOPD.

Key words: 25-Hydroxyvitamin D, C-reactive protein, Chronic obstructive pulmonary disease, Acute exacerbation

中图分类号: